Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor.
about
Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategiesPhenotypic differences between dermal fibroblasts from different body sites determine their responses to tension and TGFbeta1.Dermal fibroblasts derived from fetal and postnatal humans exhibit distinct responses to insulin like growth factorsOverview about the keloid scars and the elaboration of a non-invasive, unconventional treatmentHyaluronan synthase 2 protects skin fibroblasts against apoptosis induced by environmental stress.Keloids: The paradigm of skin fibrosis - Pathomechanisms and treatment.Expression of insulin-like growth factor-1 receptor in keloid and hypertrophic scar.The use of corticosteroids to treat keloids: a review.Normal and pathologic soft tissue remodeling: role of the myofibroblast, with special emphasis on liver and kidney fibrosis.Keloids--clinical diagnosis, pathogenesis, and treatment options.Roles of lipid metabolism in keloid development.Sphingosine may have cytotoxic effects via apoptosis on the growth of keloid fibroblasts.Expression of TGF-β1/mTOR signaling pathway in pathological scar fibroblasts.Identification of ASAH1 as a susceptibility gene for familial keloids.Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro.Suppression of insulin-like growth factor signalling pathway and collagen expression in keloid-derived fibroblasts by quercetin: its therapeutic potential use in the treatment and/or prevention of keloids.Chemokines and Their Receptors Are Key Players in the Orchestra That Regulates Wound Healing.An increase of MMP-1 is stimulated by sphingosine in keloid fibroblasts.FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids.
P2860
Q24595036-E498975A-026C-4E13-A229-42943C0134DAQ24803687-E71BD295-5987-4B00-B039-91D373DF28DBQ33305278-C8A9E4E8-BBB3-414D-A1A6-6FDBA4CCA0B0Q33725897-C9724B4F-1781-4768-A2CD-89B8125DC693Q34509837-533C8F39-CBA8-4ACF-B939-4A2CBF00AA80Q34512378-60A44BD5-881B-450B-9A81-0B0B8420545CQ34513143-3345897B-1BB4-4FF7-8AF4-3757495A66FFQ34793757-2A3F5CFC-20CD-4DE5-9E85-C105F5D6ADBEQ35613902-61375FD7-F189-4670-B526-C69E9D1209D4Q36310772-CBA2A7B0-C772-4D7F-A8DB-A130079340E8Q38103314-BD9D2FC2-B503-4861-B978-BE3B7838AC66Q38518339-9ABEB87B-ED45-4583-A1EF-F17E3D306E79Q38845128-0BABEAFD-5B09-4A27-AB82-E9BAD5E6D762Q40046884-98F053E8-1E65-433C-AD2D-DED645F40925Q40666079-87774529-0A37-4FA4-80A0-5E42E8765928Q42438679-4FC555B8-5113-428A-8862-661D3D5DDBBCQ42862270-23F48172-87C6-4590-869C-187B367CE953Q46500754-0F818F69-D02B-44F0-B891-1267E5D2231EQ54312563-6C4FBE9F-B811-4956-84F7-9591068DE8A5Q54967102-A9BF634C-A7FE-415D-986D-63136BCA3BAD
P2860
Keloid fibroblasts resist ceramide-induced apoptosis by overexpression of insulin-like growth factor I receptor.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Keloid fibroblasts resist cera ...... like growth factor I receptor.
@en
Keloid fibroblasts resist cera ...... like growth factor I receptor.
@nl
type
label
Keloid fibroblasts resist cera ...... like growth factor I receptor.
@en
Keloid fibroblasts resist cera ...... like growth factor I receptor.
@nl
prefLabel
Keloid fibroblasts resist cera ...... like growth factor I receptor.
@en
Keloid fibroblasts resist cera ...... like growth factor I receptor.
@nl
P2093
P1476
Keloid fibroblasts resist cera ...... like growth factor I receptor.
@en
P2093
Ishihara H
Murakami R
Yoshimoto H
P304
P356
10.1046/J.1523-1747.2000.00180.X
P407
P577
2000-12-01T00:00:00Z
P5875
P6179
1032448130